Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ||
Founding Date | Founding Date 2018 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ Cambridge, US South San Francisco, US | Locations Berkeley, US HQ |
Employees | Employees 42110% increase | Employees 15815% increase |
Valuation ($) | Valuation ($) 840.9 m | Valuation ($) 174.4 m |
Financial | ||
Net income | Net income ($283.3m) (FY, 2023) | Net income ($102.1m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 700m | Total funding raised $ 159.5m |